Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display

Journal of the Neurological Sciences

Volumn 224, Issue 1-2, 2004, Pages 77-82

  Schluesener, Hermann J ^a   Xianglin, Tan ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Guangzhou No 12 Hospital   (China)

Author keywords

Angiogenesis; Blood brain barrier; Glioblastoma; Microvessel; Phage display

Indexed keywords

ANGIOGENIC FACTOR; HEPTAPEPTIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; SPLEEN CELL; TUMOR CELL;

EID: 4644275378     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.06.010     Document Type: Article

References (47)

1. N. Oku, T. Asai, K. Watanabe, K. Kuromi, M. Nagatsuka, and K. Kurohane Anti-neovascular therapy using novel peptides homing to angiogenic vessels Oncogene 21 2002 2662 2669
2. E. Ruoslahti, and D. Rajotte An address system in the vasculature of normal tissues and tumors Annu. Rev. Immunol. 18 2000 813 827
3. S.O. Rahaman, P. Sharma, P.C. Harbor, M.J. Aman, M.A. Vogelbaum, and S.J. Haque IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells Cancer Res. 62 2002 1103 1109
4. C. Hao, I.F. Parney, W.H. Roa, J. Turner, K.C. Petruk, and D.A. Ramsay Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation Acta Neuropathol. 103 2002 171 178
5. M.H. Deininger, R. Meyermann, K. Trautman, M. Morgalla, F. Duffner, and E.H. Grote Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression Brain Res. 885 2000 111 116
6. W. Pan, W.A. Banks, and A.J. Kastin Permeability of the bloodâ€"brain and blood spinal cord barriers to interferons J. Neuroimmunol. 76 1997 105 111
7. W.M. Pardridge, J.L. Buciak, and P.M. Frieden Selective transport of an antitransferrin receptor antibody through the bloodâ€"brain barrier J. Pharmacol. Exp. Ther. 259 1991 66 70
8. W.M. Pardridge, Y.S. Kang, J.L. Buciak, and J. Yang Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood barrier in vivo in the primate Pharm. Res. 6 1995 807 816
9. M. Fukuta, H. Okada, S. Iinuma, S. Yanai, and H. Toguchi Insulin fragments as a carrier for peptide delivery across the bloodâ€" brain barrier Pharm. Res. 11 1994 1681 1688
10. L.A. Lampson, P. Wen, V.A. Roman, J.H. Morris, and J.A. Sarid Disseminating tumor cells and their interactions with leukocytes visualized in the brain Cancer Res. 52 1992 1018 1025
11. R. Pasqualini, and E. Ruoslathi Organ targeting in vivo using phage display peptide libraries Nature 380 1996 364 366
12. R. Pasqualini, E. Koivunen, and E. Rouslahti Alpha V integrin as receptors for tumor targeting by circulating ligands Nat. Biotechnol. 15 1997 542 546
13. E. Koivunen, B. Wang, C.D. Dickinson, and E. Ruoslahti Peptides in cell adhesion research Methods Enzymol. 245 1994 346 369
14. H.J. Schluesener, K. Seid, and R. Meyermann Effect of autoantigen and dexamethasone treatment on expression of endothelialâ€"monocyte activating polypeptide II and allograft-inflammatory factor-l by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis Acta Neuropathol. 7 1999 119 126
15. H.J. Schluesene, K. Seid, Y. Zhao, and R. Meyermann Localization of endothelialâ€"monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells Glia 20 1997 365 372
16. H.J. Schluesener, K. Seid, J. Kretzschmar, and R. Meyermann Allograft-inflammatory factor-1 in rat experimental autoimmune encephalomyelitis, neuritis, and uveitis: expression by activated macrophages and microglial cells Glia 24 1998 244 251
17. E. Ruoslahti, and D. Rajotte An address system in the vasculature of normal tissues and tumors Annu. Rev. Immunol. 18 2000 813 827
18. J. Folkman Addressing tumor blood vessels Nat. Biotechnol. 15 1997 510
19. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
20. M. Skobe, P. Rockwell, N. Goldstein, S. Vosseler, and N.E. Fusenig Halting angiogenesis suppresses carcinoma cell invasion Nat. Med. 3 1997 1222 1227
21. E.L. Lund, M. Spang-Thomsen, H. Skovgaard-Poulsen, and P.E. Kristjansen Tumor angiogenesisâ€"a new therapeutic target in gliomas Acta Neurol. Scand. 97 1998 52 62
22. P. Wesseling, D.J. Ruiter, and P.C. Burger Angiogenesis in brain tumors: pathobiological and clinical aspects J. Neurooncol. 32 1997 253 265
23. D. Rajotte, W. Arap, M. Hagedom, E. Koivunen, R. Pasqualini, and E. Ruoslahti Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display J. Clin. Invest. 102 1998 430 437
24. B. Carnemolla, D. Neri, P. Castellani, A. Leprini, G. Neri, and A. Pini Phage antibodies with pan-species recognition of the oncofoetal angiogenenesis marker fibronectin ED-B domain Int. J. Cancer 68 1996 397 405
25. J.M. Healy, O. Murayama, T. Maeda, K. Yoshino, K. Sekiguchi, and M. Kikuchi Peptide ligands for integrin alpha v beta 3 selected from random phage display libraries Biochemistry 34 1995 3948 3955
26. E. Koivunen, B. Wang, and E. Ruoslathi Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins Biotechnol. 13 1995 265 270
27. J.N. Rich The role of transforming growth factor-beta in primary brain tumors Front Biosci. 8 2003 E245 E260
28. P. Auguste, D.B. Gursel, S. Lemiere, D. Reimers, P. Cuevas, and F. Carceller Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms Cancer Res. 61 2001 1717 1726
29. M. Tamaki, M. Aoyagi, I. Morita, K. Hirakawa, and S. Murota Cell adhesion molecules acting between C6 glioma and endothelial cells J. Neurooncol. 24 1995 181 188
30. J.B. Dietrich, M. Zaepfel, and S. Kuchler-Bopp Expression of intercellular adhesion molecule-1 in C6 glioma cells is up-regulated by thyroid hormone NeuroReport 11 2000 2855 2860
31. K. Meerovitch, F. Bergeron, L. Leblond, B. Grouix, C. Poirier, and M. Bubenik A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen Vascul. Pharmacol. 40 2003 77 89
32. S. Chatterjee, A. Matsumura, J. Schradermeier, and G.Y. Gillespie Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents J. Neurooncol. 46 2000 144 235
33. C. Ruegg, O. Dormond, and A. Foletti Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target? Endothelium 9 2002 151 160
34. J.G. Flanagan, and P. Vanderhaeghen The ephrins and Eph receptors in neural development Annu. Rev. Neurosci. 21 1998 309 345
35. V.C. Dodelet, and E.B. Pasquale Eph receptors and ephrin ligands: embryogenesis to tumorigenesis Oncogene 19 2000 5614 5619
36. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
37. B.L. Tang ADAMTS: a novel family of extracellular matrix proteases Int. J. Biochem. Cell Biol. 33 2001 33 44
38. M.E. Clark, G.S. Kelner, L.A. Turbeville, A. Boyer, K.C. Arden, and RA. Maki ADAMTS9, a novel member of the ADAM-TS/metallospondin gene family Genomics 67 2000 343 350
39. H. Birkedal-Hansen Proteolytic remodeling of extracellular matrix Curr. Opin. Cell Biol. 7 1995 728 735
40. E. Koivunen, W. Arap, H. Valtanen, A. Rainisalo, O.P. Medina, and P. Heikkilla Tumor targeting with a selective gelatinase inhibitor Nat. Biotechnol. 17 1999 768 774
41. H. Nishimori, T. Shiratsuchi, T. Urano, Y. Kimura, K. Kiyono, and K. Tatsumi A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis Oncogene 15 1997 2145 2150
42. D.G. Duda, M. Sunamura, L. Lozonschi, T. Yokoyama, T. Yatsuoka, and F. Motoi Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis Br. J. Cancer 86 2002 490 496
43. B. Kaur, D.J. Brat, C.C. Calkins, and E.G. Van Meir Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression Am. J. Pathol. 162 2003 19 27
44. D. Neri, B. Carnemolla, A. Nissim, A. Leprini, G. Querze, and E. Balza Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform Nat. Biotechnol. 15 1997 1271 1275
45. R. Pasqualini, E. Koivunen, and E. Ruoslathi αv integrins as receptors for tumor targeting by circulating ligands Nat. Biotechnol. 15 1997 542 546
46. M. Trepel, W. Arap, and R. Pasqualini In vivo phage display and vascular heterogeneity: implications for targeted medicine Curr. Opin. Chem. Biol. 6 2002 399 404
47. M. Blank, T. Weinschenk, M. Priemer, and H.J. Schluesener Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels: selective targeting of endothelial regulatory protein pigpen J. Biol. Chem. 276 2001 16464 16468